Welcome to the breast cancer page!

Whether you or someone you love has breast cancer, you've come to the right place!

Bookmark us now for the latest infomation on breast cancer research, breast cancer remedies, breast cancer risk, breast cancer prevention, screening, symptoms, diagnois, treatment and support for all people that have breast cancer

Breast Cancer

INCIDENCE

Breast cancer is the most common malignancy among women and has the highest fatality rate of all cancers affecting this sex. It is the leading cause of death among women aged 35-54. In 1999 an estimated 175,000 women were diagnosed with breast cancer. That is one woman every three minutes. At the same time 43,000 will die, at the rate of one every two minutes. The incidence of men diagnosed with breast cancer is rare, however it does occur. Approximately 1,300 men a year are diagnosed, and 400 die annually due to the disease. A total of 75% of all breast cancers occur in women with no known risk factors. 80% of breast cancers occur in women aged 50 and up. The mortality rate would decrease if every woman over 50 was informed and followed guidelines. When confined to the breast, the survival rate is 95%. Studies have shown that more white women than black women get breast cancer, however more black women die of breast cancer because they are not diagnosed at an early stage.

SIGNS AND SYMPTONS

Most breast cancers appear as a slowly growing, painless mass, though a vague discomfort may be present. Physical signs include a retracted nipple, bleeding from the nipple, distorted areola or breast contour, skin dimpling over the lesion, attachment of the mass to surrounding tissues including the underlying fascia and overlying skin, and enlarged lymph nodes. In most advanced stages of the disease the skin nodules with ultimate breakdown and ulcer formation may be seen. Metastases should be sought immediately so that further spread will not be a factor. Among the common sites of metastases are the lungs and pleura, the skeleton (specifically the spine, pelvis, and skull), and the liver. Whenever possible, distant spread of the disease should be confirmed by a lymph nose biopsy, by x-ray, or by liver and bone scans using radioactive isotopes.

WHO IS AT RISK?

All women and men are at risk of getting breast cancer. However personal history with family members having breast cancer adds an increase to the risk factor. Contradictory to this though studies have shown that 75% of breast cancer occurs in women with no history and no known risk factors. Not ever having children, or having ones first child after 30 yrs., also increases the risk of breast cancer in women. Heavy alcohol abuse is a risk factor as well. Studies have also shown that women who began menstruation early, twelve years or less, and women who began menopause late, fifty-five years plus, also have a greater risk of breast cancer.

PREVENTION

There are three ways to attempt to detect prevention, however since there is no cure, one cannot determine what actions to take to prevent. The most common technique for early detection is by a regular doctors examination. The second technique at detecting breast cancer is by a breast self-examination (BSE), and lastly, by mammogram. BSE should begin when a woman is eighteen or older, so that the breast is fully developed. During the BSE women should begin to learn what is normal and what is not in their breasts. Mammography is the best method at detecting breast cancer. A woman should have a mammogram when she is 40 yrs. old, and then one every two years until she is 50 yrs. old. Once a woman is 50 yrs. old she should have a mammogram annually because as ones age increases, so does the risk of getting breast cancer. Many women also need to be educated about the risks of breast cancer and how to detect it early. The majority of women with breast cancer do not know about the fortunateness of detecting breast cancer early, never mind follow the detection guidelines.

TREATMENT

Therapy depends mainly on the extent of the disease and the patient's age. If there is evidence of wider metastasic spread, treatment will be palliative. This means that treatment will lessen the severity of pain, however it will not cure. When there is no evidence of spread, the treatment of choice is total mastectomy and modified radical mastectomy. This is an entire or partial removal of the affected breast. In the best circumstances, the 10 yr. survival rate is greater than 50%. However these "clinical cures" may recur with fatal outcome as late as 20 yr after surgery. Total or Partial Mastectomy Is now accepted as an equivalent alternative to conventional radical mastectomy for the treatment of all primary operable breast cancers. The entire, or partial area of, breast is removed together with virtually all of the axillary lymph nodes, but since the pectoral muscles are preserved their function is left intact, the cosmetic result is far superior. In addition, the procedure leads to far better breast reconstruction using implants that often can be inserted 6-12 mos. after surgery. Radiotherapy This technique is sometimes used instead of surgery. After a radical Mastectomy if additional metastases are found, the internal lymph node chain may be irradiated because of the high incidence of occult lymph node metastases in this area when the disease has already reached the axilla. For recurrent cancer, palliative radiotherapy can be valuable in controlling local chest wall or cervical lymph node recurrences and relieving pain from skeletal metastases. Irradiation is of little value for large internal metastases. Hormonal Therapy This treatment has proven to be of the greatest use in palliation of symptoms or in delaying the advancement of breast cancer. It is most often combined with radiotherapy when cancer recurs following a mastectomy and when the tumour is so advanced that surgery is not indicated or is palliative. Chemotherapy Chemotherapy is useful in patients that have a high risk of developing recurrent cancer after a mastectomy.. Chemotherapy is used in the management of patients with recurrent breast cancer usually after the failure of previous hormonal manipulations. A variety of chemotherapeutic agents are used in various combinations, sometimes with a corticosteroid to suppress endogenous adrenal function or with the estrogen antagonist tamoxifen. (Quote) The agents in chemotherapy have demonstrated value in halting or delaying the appearance of metastases, especially in premenopausal patients, and in treating recurrences.





Breast Cancer News

26 Jun 2009 at 7:00am
Reviewing the records of 577 breast cancer patients, Fox Chase Cancer Center researchers found that women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment.
9 Jun 2009 at 10:00pm
Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell.
7 Jun 2009 at 10:00pm
(American Cancer Society) A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown.
12 Jun 2009 at 7:00am
Testing for genetic mutations can help identify breast cancer patients who do not benefit from a certain type of chemotherapy, according to a study published Tuesday in the journal Clinical Cancer Research, Reuters reports. The study included 588 breast cancer patients in the U.S. and Norway. Some of the subjects received chemotherapy, while some did not.
3 Jun 2009 at 11:33pm
Ten-year-old Hannah Powell-Auslam is trying to remain brave as she copes with a rare form of breast cancer.
26 Jun 2009 at 8:00am
The drug, called olaparib, specifically targets hereditary cancer caused by faulty BRCA1 and BRCA2 genes. The small scale patient trial has shown remarkable benefit for patients with breast, ovarian and prostate cancer.
24 Jun 2009 at 10:00pm
If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps are benign. A recent study published in the American Journal of Roentgenology suggests that a breast ultrasound might eliminate the need for biopsy in many cases.
9 Jun 2009 at 7:11am

Learn the truth about mammograms, hormone replacement therapy, vitamin D levels and breast cancer, and more.

27 Jun 2009 at 9:00am
UroToday.com - Prostate and breast cancer appear to be homologous cancer in males and females respectively. Both cancers share hormone etiologies and are treated with hormonal manipulation. The incidence of these two hormone-dependent cancers has steadily risen throughout the twentieth century.
16 Jun 2009 at 7:00am
A low cellular level of a tiny fragment of RNA appears to increase the spread of breast cancer in mouse models of the disease, according to researchers at Whitehead Institute for Biomedical Research.
14 Jun 2009 at 10:00pm
(Society of Nuclear Medicine) A prototype breast imaging system combining positron emission tomography and magnetic resonance imaging technologies could greatly improve breast cancer imaging capabilities, according to researchers at SNM's 56th Annual Meeting.
29 Jun 2009 at 10:00pm
(American Association for Cancer Research) Physiological changes associated with the metabolic syndrome may play a role in the risk of postmenopausal breast cancer, according to study results published in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
17 Jun 2009 at 12:04pm
Another significant milestone in my life has been reached. Last Friday I had my 50th birthday! I share my birthday with my husband, who is a couple of years older, but having been born on the same day assures me that he won?t ever forget it. For breast cancer survivors decade birthdays like this one [...]
8 Jun 2009 at 6:00am
Checking lymph nodes during surgery and assessing the hormone status of tumours could help improve breast cancer survival in the UK, according to research published today in Annals of Oncology.
30 Jun 2009 at 10:00pm
(Journal of the National Cancer Institute) The single-nucleotide polymorphism known as 2q35-rs13387042 is associated with increased risk of estrogen receptor-positive and -negative breast cancer, according to a study published online July 1 in the Journal of the National Cancer Institute.